MSI_000007117

Reliable

排名分数: 6.7
参考来源: Rattus norvegicus (UBERON:0004359: corpus epididymis)

M/z: 334.2082
Mass Window: 334.2081 ~ 334.2084 (1.3 ppm)

参考注释

Proglumide_[M]+ (BioDeep_00000182625)
4-(dipropylcarbamoyl)-4-{[hydroxy(phenyl)methylidene]amino}butanoic acid

Formula: C18H26N2O4 (334.18924760000004)
SMILES: CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Proglumide is a nonpeptide and orally active cholecystokinin (CCK)-A/B receptors antagonist. Proglumide selective blocks CCK’s effects in the central nervous system (CNS). Proglumide has ability to inhibit gastric secretion and to protect the gastroduodenal mucosa. Proglumide also has antiepileptic and antioxidant activities[1][2][3][4][5].